Table 3.
Prediction of longterm survival by histological measures and body composition in patients with pancreatic cancer
| Value |
Cox's regression analysis |
|||
|---|---|---|---|---|
| Univariate probability | Multivariate probability | HR and 95% CI for Cox's multivariate analysis | ||
| Stage, n | 0.740 | |||
| IA | 3 | |||
| IB | 1 | |||
| IIA | 14 | |||
| IIB | 16 | |||
| III | 2 | |||
| Grade, n | 0.074 | |||
| 1 | 1 | |||
| 2 | 20 | |||
| 3 | 13 | |||
| 4 | 2 | |||
| Margin involved, n | 12 | 0.048 | 0.001 | 0.22 (0.09–0.51) |
| Posterior margin, n | 15 | 0.081 | ||
| Neck margin, n | 3 | N/A | ||
| Neural spread, n | 23 | 0.275 | ||
| Intravascular spread, n | 18 | 0.004 | 0.010 | 2.96 (1.29–6.80) |
| Lymph node metastases, n | 25 | 0.380 | ||
| Number of involved nodes, median (range) | 1 (0–9) | 0.047 | ||
| Tumour size, mm, median (range) | 30 (5–50) | 0.013 | ||
| Fat mass, kg, mean (SD) | 20.8 (8.5) | 0.130 | 0.039 | 1.06 (0.09–0.51) |
| TBN, g, mean (SD) | 1.80 (0.20) | 0.041 | ||
HR, hazard ratio; 95% CI, 95% confidence interval; N/A, not applicable; SD, standard deviation; TBN, total body nitrogen